Oncorus Inc (ONCR) Stock

DelistedNasdaq: ONCROncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients.

0.12
Final close · Jun 20, 2023

ONCR is no longer traded. Oncorus Inc was delisted from the Nasdaq in June 2023.

Prices on this page are historical; the last trade was June 20, 2023 at $0.12.

Oncorus Inc stock price history

Split-adjusted closes, 2020–2023

ONCR final trading statistics

Final close
$0.12
Final trading day
Jun 20, 2023
Market cap at delisting
$3.15M
Shares outstanding
26.09M
Final 52-week range
$0.07 – $1.70
Avg. volume (final 3 mo.)
4,511,422
All-time high (split-adj.)
$35.55 · Jan 2021
All-time low (split-adj.)
$0.00 · May 2008
Return since IPO
+7940.0%
Beta
1.95
Book value / share
$1.19
Price / book
0.10
Final 52 wk
0.071.70

Oncorus Inc earnings per share

Earnings per share

Oncorus Inc revenue & net income

RevenueNet income

Oncorus Inc annual financials

Oncorus Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2022$0.00-$78.3M-$3.00
FY2021$0.00-$64.7M-$2.55
FY2020$0.00-$46.8M-$23.43
FY2019$0.00-$30.2M—
FY2018$0.00-$18.0M—

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Oncorus Inc

Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company develops ONCR-021 for the treatment of non-small cell lung cancer, renal cell carcinoma, melanoma, and anaplastic thyroid cancer; and ONCR-788 for the treatment of small cell lung cancer, neuroendocrine prostate, and other neuroendocrine cancers. Oncorus, Inc. was incorporated in 2015 and is headquartered in Andover, Massachusetts.

Oncorus Inc stock FAQ

What happened to Oncorus Inc stock?

Oncorus Inc stock was delisted from the Nasdaq. Its final close was $0.12 on June 20, 2023.

Is ONCR stock still trading?

No. ONCR was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.

What was the last price of ONCR stock?

ONCR closed at $0.12 on its final trading day, June 20, 2023, for a market value of about $3.15M.

What were Oncorus Inc's revenue and earnings in its last full fiscal year?

Oncorus Inc reported revenue of $0.00 and net income of -$78.3M in fiscal 2022, its last full year as a public company.

When did Oncorus Inc go public?

Oncorus Inc stock began trading on October 2, 2020.

Biotechnology stocks to research

All Healthcare stocks →